NAPOLEONVILLE, LA / ACCESSWIRE / February 7, 2022 / Impact Fusion International, Inc. (OTC PINK:IFUS)Letter to Our Shareholders:Our premier product,…
STIMO-BRIDGE Study Results Published in Nature Medicine EINDHOVEN, Netherlands & LAUSANNE, Switzerland--(BUSINESS WIRE)--THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE…
Bolsters executive leadership with addition of chief commercial officer, Matt Titus, to lead next phase of business expansion WATERTOWN, Mass.--(BUSINESS…
HAMILTON, BERMUDA / ACCESSWIRE / February 7, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…
VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased…
Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled21 clinical sites in the…
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and…
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…
ROSELAND, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,…
Optimi Health to become a global leader in all-natural psilocybin productionVANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Optimi…